It is researched and continuously developed with expansion of the product portfolio

NordicDx

NordicDx AS is a Norwegian-registered company that is an importer and distributor of innovative medical equipment for the Scandinavian market. We are the exclusive dealer for the biotechnology companies GeneMe and SensDx.

Here are some products we have under development

Aneury SensDx Assay - Blood test for the detection of abdominal aortic aneurysms (AAA).

Aneury SensDx identifies specific biomarkers in the blood that provide a rapid and non-invasive diagnosis of effusion on the main artery. The biomarkers can also be used as a tool to monitor the development and severity of the bagging. The condition is often asymptomatic, and the consequences of delayed diagnosis can lead to very serious complications.

Intimate SensDx Assay - Diagnosis of STDs

The diseases that are being researched include HPV, HSV-1, HSV-2, chlamydia trachomatis and bacterial vaginismus. The plan further is to develop a product that can detect up to 7 pathogenic microorganisms that cause sexually transmitted diseases.

Uro SensDx Assay - Urine Samples

The product will be developed with the aim of identifying up to 7 conditions in a joint test.

Strepto SensDx Assay - Sore Throat

Upper respiratory tract infections are a common cause of patients contacting their GP. Strepto SensDx is a rapid diagnostic test for the identification of Streptococcal bacteria in the throat.

Multi SensDx Assay - Respiratory tract infections

A test that detects up to several different infections in the respiratory tract.

EBV SensDx Assay - Mononucleosis (Kiss Disease)

The "Epstein Barr" virus is one of several viruses that cause kissing disease. This virus can cause similar symptoms as the bacterium "Streptococcus Pyogenes". The diseases have various complications if left untreated and it is important with the right diagnosis to initiate the right treatment. This test enables this.

SensDx products

$

Mobi SensDx

Mobi SensDx is the base for SensDx's technology. It is a multi-purpose diagnostic platform.

$

Flu SensDx

This product was launched in Poland in the autumn of 2019, and is already used at 100 doctors' offices and hospitals in the country.

$

SARS-CoV-2 test

The first internal evaluation of the SARS-CoV-2 test was performed on 100 positive and 500 negative samples with 92 % sensitivity and 98.5 % specificity.

$

Products under development

It is continuously researched and developed with the expansion of the product portfolio. Here are some products we have under development.

$

Products under development

It is continuously researched and developed with the expansion of the product portfolio. Here are some products we have under development.